We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Exagamglogene autotemcel for treating severe sickle cell disease in people 12 years and over TA1044 26 February 2025 26 February 2025 Durvalumab with etoposide and either carboplatin or cisplatin for ...

Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer [ID5110] Draft guidance Technology appraisal guidance 27 March ...

by unlocking targets that have been inaccessible to traditional small molecule discovery approaches,” Abraham Heifets, co-founder and CEO of Atomwise, said in a statement. “We are pleased to ...

At one memorable panel at Fierce JPM Week, Vivodyne CEO Abraham Heifets described how tech and pharma are almost opposites in how they do business: tech companies secure a first-mover advantage ...

After hours: March 14 at 7:48:04 PM EDT Loading Chart for NICE ...